NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Medicines Update

Nadolol discontinued

Nadolol is a beta blocker used mainly in the treatment of arrhythmias. The branded Corgard tablets have been discontinued by the manufacturer for commercial (not safety) reasons. There are unlicensed versions still available. Those patients using nadolol for other common beta blocker indications, eg angina or hypertension can be transferred to other beta blockers. For those being treated for arrhythmias, advice from cardiology specialists is:



  • Existing nadolol patients should, where possible, be continued on it using an unlicensed product. Prescribing should be undertaken in line with the NHSGGC Unlicensed Medicines Policy
  • For paediatric patients, specialists are contacting GPs of affected patients to advise on ongoing arrangements.  Many paediatric patients will require the liquid formulation.
  • If nadolol is temporarily unavailable, bisoprolol can be used until nadolol becomes available again. The conversion is nadolol 80mg to bisoprolol 5mg.
  • New patients may be started on either nadolol or bisoprolol by cardiologists based on the perceived risk of arrhythmia.


Published 31/08/2016